• Home
  • Search Results
  • Drag-reducing polymers: a novel class of diuretic and natriuretic compounds.

Drag-reducing polymers: a novel class of diuretic and natriuretic compounds.

Cardiovascular drugs and therapy (1990-02-01)
D D Smyth, P I Polimeni
ABSTRACT

Previous studies have demonstrated that Separan AP-30, a drag-reducing polymer, significantly decreased the formation of atherosclerotic plaques in rabbits fed a high-cholesterol diet. Furthermore, Separan AP-273, a polymer similar to but longer than Separan AP-30, markedly increased cardiac output in open-chest rats. Preliminary studies in our laboratory have described diuresis and natriuresis following the intravenous infusion of Separan AP-273. These studies did not determine whether this natriuresis was common to drag-reducing polymers or unique to Separan. In the present study the renal effects of two chemically dissimilar drag-reducing polymers of molecular lengths approaching approximately 100 microns were compared. Sprague-Dawley rats (250-300 g) were anesthetized (Nembutal) and a tracheostomy was performed. A baseline level of sodium and water excretion was established by the infusion of saline (0.097 ml/min, IV). Separan (0.004%), an anionic polyacrylamide; Polyox (0.4%), a poly(ethylene oxide); or mannitol (20%), an osmotic diuretic, was infused into the jugular vein at 0.0034 ml/min. Separan and Polyox both increased the excretion of sodium and water (p less than 0.05). At the doses tested, potassium excretion was unaltered in both groups. Separan, but not Polyox, produced a modest increase in blood pressure. Creatinine clearance was unaltered. At this infusion rate, only hypertonic concentrations of mannitol (20%) induced a similar effect. These results indicate that drag-reducing polymers may represent a novel class of potassium-sparing diuretic and natriuretic compounds. The ability of this class of polymers to decrease the formation of atherosclerotic plaques, increase blood flow, and produce a potassium-sparing natriuresis may be of practical clinical significance.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Poly(ethylene glycol), BioUltra, 8,000
Sigma-Aldrich
Poly(ethylene glycol), average Mn 400
Sigma-Aldrich
Poly(ethylene glycol), for molecular biology, average mol wt 8,000
Sigma-Aldrich
Poly(ethylene glycol), average Mn 6,000
Sigma-Aldrich
Poly(ethylene glycol), average Mn 3,350, powder
Sigma-Aldrich
Poly(ethylene glycol), average mol wt 200
Sigma-Aldrich
Poly(ethylene oxide), average Mv 100,000, powder
Sigma-Aldrich
Poly(ethylene glycol), average mol wt 8,000, powder
Sigma-Aldrich
Poly(ethylene glycol), BioXtra, average mol wt 3,350, powder
Sigma-Aldrich
Poly(ethylene glycol), BioUltra, 4,000
Sigma-Aldrich
Poly(ethylene glycol), tested according to Ph. Eur., 6,000
Sigma-Aldrich
Poly(ethylene glycol), average Mn 20,000
Sigma-Aldrich
Poly(ethylene oxide), average Mv 600,000, powder
Sigma-Aldrich
Poly(ethylene glycol), BioUltra, 400
Sigma-Aldrich
Poly(ethylene glycol), BioUltra, for molecular biology, 8,000
Sigma-Aldrich
Poly(ethylene glycol), BioUltra, 2,000
Sigma-Aldrich
Kollisolv® PEG E 400
Sigma-Aldrich
Polyethylene glycol solution, Hybri-Max, 50 % (w/v), average mol wt 1,450, sterile-filtered, BioReagent, suitable for hybridoma
Sigma-Aldrich
Polyethylene glycol solution, 40 % (w/w) in H2O, average mol wt 8,000
Sigma-Aldrich
Poly(ethylene glycol), average Mn 300
Sigma-Aldrich
Poly(ethylene glycol), BioUltra, for molecular biology, 6,000
Sigma-Aldrich
Poly(ethylene glycol), average Mn 4,000, platelets
Sigma-Aldrich
Poly(ethylene glycol), 35,000
Sigma-Aldrich
Poly(ethylene glycol), BioUltra, 20,000
Sigma-Aldrich
Poly(ethylene glycol), BioUltra, 6,000
Sigma-Aldrich
Poly(ethylene glycol), tested according to Ph. Eur., 400
Sigma-Aldrich
Poly(ethylene oxide), average Mv ~1,000,000, powder
Sigma-Aldrich
Poly(ethylene glycol), BioUltra, 3,350
Sigma-Aldrich
Poly(ethylene glycol), average mol wt 400
Sigma-Aldrich
Poly(ethylene glycol), average Mn 600, waxy solid (moist)

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.